BRIEF-Durect completes enrollment in persist, phase 3 trial for Posimir By: Reuters: Company News June 22, 2017 at 07:30 AM EDT * Durect completes enrollment in Persist, phase 3 trial for Posimir Read More >> Related Stocks: Durect Corp